Icosavax

Developer of computationally designed VLP vaccines for treating multiple infections

placeSeattle, Washington, United States calendar_todayFounded 2017 groups60 employees language icosavax.com

Registered entities

Social engagement

Social engagement: 3.9M social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

15 investors on record; lead investors include RA Capital Management, Qiming.

Investor typeCountShare
Venture capital960%
Private equity213%
Other / undisclosed427%

Recent activity

30 Jun 2026
Event
AstraZeneca Ambassadors Program 2026/2027
19 Jun 2026
Partnership
Consultorio Amazonas
17 Jun 2026
Recognition
Coming soon